Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.neulet.2005.12.083
DC FieldValue
dc.titleA comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked rats
dc.contributor.authorLoh, K.P.
dc.contributor.authorLow, L.S.
dc.contributor.authorWong, W.H.
dc.contributor.authorZhu, Y.Z.
dc.contributor.authorZhou, S.
dc.contributor.authorHuang, S.H.
dc.contributor.authorDuan, W.
dc.contributor.authorDe, Silva R.
dc.contributor.authorChou, W.H.
dc.date.accessioned2011-09-29T06:42:57Z
dc.date.available2011-09-29T06:42:57Z
dc.date.issued2006
dc.identifier.citationLoh, K.P., Low, L.S., Wong, W.H., Zhu, Y.Z., Zhou, S., Huang, S.H., Duan, W., De, Silva R., Chou, W.H. (2006). A comparison study of cerebral protection using Ginkgo biloba extract and Losartan on stroked rats. Neuroscience Letters 398 (1-2) : 28-33. ScholarBank@NUS Repository. https://doi.org/10.1016/j.neulet.2005.12.083
dc.identifier.issn03043940
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/27411
dc.description.abstractIt has been well documented that oxidative stress is involved in stroke. Currently, many neuroprotective strategies have been targeted at molecules that are able to act as an oxidant to intervene with free-radical mediated apoptosis in the ischemic penumbra. In particular, natural products which contain antioxidant properties have undoubtedly efficacious for stroke treatment. In the current study, therapeutic effects of Ginkgo biloba extract (EGb) against cerebral protection in Wistar rats underwent middle cerebral artery occlusion (MCAO) was evaluated. A comparison study was conducted by using Losartan, an antihypertensive drug. Gene expression levels of pro-apoptotic genes (AT2 receptor, Fas, Bax and Bcl-xS) have shown to have significant reduction by EGb- and Losartan-treated groups as compared to vehicle group. Significant reduction of immunoreactivity of protein production of these genes, together with least nuclear green fluorescence observed in TUNEL, EGb, as an antioxidant drug, is concluded to have potent and promising therapeutic effect for stroke treatment. © 2005 Elsevier Ireland Ltd. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.neulet.2005.12.083
dc.sourceScopus
dc.subjectCerebral protection
dc.subjectGinkgo biloba extract
dc.subjectLosartan
dc.subjectRats
dc.subjectStroke
dc.typeArticle
dc.contributor.departmentBIOCHEMISTRY
dc.contributor.departmentCHEMISTRY
dc.contributor.departmentPHARMACY
dc.contributor.departmentPHARMACOLOGY
dc.description.doi10.1016/j.neulet.2005.12.083
dc.description.sourcetitleNeuroscience Letters
dc.description.volume398
dc.description.issue1-2
dc.description.page28-33
dc.identifier.isiut000236914500006
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

14
checked on Jul 3, 2020

WEB OF SCIENCETM
Citations

13
checked on Jul 3, 2020

Page view(s)

350
checked on Jun 30, 2020

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.